If a supplied lot fails agreed specifications, we’ll replace it at no cost or refund its purchase price in full.
Quality test failed? Free replacement or full refund.
Off-spec? Free replacement or full refund.
FDA PCAC reviews 7 peptides for the 503A bulks list (BPC-157, KPV, TB-500, MOTs-C, Emideltide, Semax, Epitalon). Read our compounder's decision tree. Read our briefing →
FDA PCAC reviews 7 peptides for the 503A bulks list in July. Read →
FDA PCAC: 7 peptides under review. Read →
Mitochondrial-derived peptide
Batch documentation
Ask sales for the MOTS-c (Human) COA matched to the offered batch. Review the recorded tests, specifications, and results against your QA and destination-market requirements before quotation.
Overview
Sequence MRWQEMGYIFYPRKLR, 16 residues, encoded inside the 12S rRNA region of the human mitochondrial genome, MOTS-c is one of the better-characterised members of the mitochondrial-derived peptide (MDP) class. MDPs are a relatively recent addition to the peptide therapeutics universe: they are translated from short open reading frames sitting inside mitochondrial ribosomal RNAs, a class of peptides the textbooks did not acknowledge until the early 2010s. MOTS-c signalling itself runs retrograde, from mitochondrion to nucleus, through AMPK-axis activation; the published research portfolio spans glucose metabolism, insulin-sensitivity endpoints, exercise-capacity studies, body-weight regulation, and the broader landscape of age-related mitochondrial decline. For 503A pharmacies tracking the regulatory pipeline: MOTS-c is currently scheduled on the FDA PCAC July 2026 agenda for review against the 503A bulks list, with proposed indications covering obesity and osteoporosis. For compounding pharmacy buyers, Vialdyne releases MOTS-c acetate as a lyophilised powder against a ≥99.0% main-peak HPLC specification. The batch COA that comes with every lot pairs RP-HPLC peak integration with ESI-MS at the 2174.6 Da theoretical mass, with Karl Fischer water and counter-ion quantitation available on request; LC-MS/MS sequence verification is available as a documented add-on. Plasma half-life is short, on the order of minutes to a couple of hours, so MOTS-c functions as a tool for acute mitochondrial-signalling protocols rather than sustained-elevation work, repeat dosing or sustained-release formulation is required to hold biological exposure across longer windows. Four nominal strengths from 10 to 40 mg cover both aliquot-scale bench work and small-batch dispensing inside a single qualified supplier line.
Applications & buyer fit
Mitochondrial-targeted peptides ship primarily to research labs studying OXPHOS, ROS biology, and mitochondrial dysfunction in disease models. The lipophilic / cationic character that drives mitochondrial accumulation also makes these peptides somewhat oxidation-prone in solution, working stocks should be prepared fresh or held at -80 °C rather than -20 °C when the workflow permits.
Sourced for
Buyer fit
Documentation that ships
Procurement note: The cationic / lipophilic character makes these peptides oxidation-prone in solution; working stocks are best held cold and prepared fresh.
Primary buyer fit: 503A / 503B compounding pharmacies and academic and contract research laboratories.
Specifications
Nasal spray listing · US inventory
MOTS-c (Human) is also listed in this catalog as a nasal spray solution.

Batch COAs and test reports
Each picture is a low-resolution preview of a report's first page, with batch and report numbers covered. For the full, clear report, ask our sales team, naming the product and strength.
Batch COAMOTS-c (Human) 10 mg
HPLC purity · MS identity
Batch COA
Full, clear copy from sales
Batch COAMOTS-c (Human) 15 mg
HPLC purity · MS identity
Batch COA
Full, clear copy from sales
Batch COAMOTS-c (Human) 20 mg
HPLC purity · MS identity
Batch COA
Full, clear copy from sales
Batch COAMOTS-c (Human) 40 mg
HPLC purity · MS identity
Batch COA
Full, clear copy from sales
Third-party reportMOTS-C 10 mg
HPLC purity · MS identity
Third-party laboratory, Tianjin, China
Full, clear copy from sales
Independent test fails? Full refund. How it works
Browse all COAs and reportsRegulatory note
MOTS-c is presently before the FDA's PCAC (July 2026) for addition to the 503A bulks list, the proposed indications being obesity and osteoporosis.
Selected literature
Frequently asked questions
MOTS-c was among the earliest mitochondrial-derived peptides (MDPs) identified, a class of short peptides translated from previously-overlooked open reading frames inside mitochondrial ribosomal RNA. The discovery rewrote the textbook claim that mitochondrial DNA encodes only 13 OXPHOS-subunit protein products and exposed a second layer of nucleus-targeted signalling peptides emerging from mitochondrial transcripts. MOTS-c itself signals retrograde, mitochondrion-to-nucleus, activating AMPK-axis pathways and modulating nuclear gene expression in response to metabolic stress. That mechanism is fundamentally distinct from the receptor-pharmacology playbook that dominates the rest of the metabolism and longevity peptide space.
Both molecules sit inside mitochondrial biology but engage it from opposite directions. MOTS-c is an endogenously-encoded signalling peptide that travels retrograde from mitochondrion to nucleus through AMPK and related metabolic-sensor pathways; the effect is gene-expression modulation. SS-31 (Elamipretide) is a synthetic mitochondria-targeted peptide that partitions into the inner mitochondrial membrane and physically protects cardiolipin from peroxidation; the effect is direct biochemical preservation of OXPHOS machinery. The selection criterion is the experimental endpoint, metabolic-signalling and gene-expression work points to MOTS-c, while oxidative-stress and OXPHOS-integrity work points to SS-31.
Yes. MOTS-c (Human) is listed as a nasal spray solution (10 mg), filled in 10 mL or 20 mL bottles, with an MOQ of 10 bottles per content and fill. It is dispatched within the United States from US inventory; send an inquiry for current availability.
Send any vial from your order to an independent laboratory of your choice. If the report shows the product does not meet the specification on its COA — purity below the stated minimum, or an identity that does not match — share the report with our sales team and we refund that product in full.
Related peptides
15-mer
Mitochondria-targeted tetrapeptide (Szeto-Schiller)
Nasal spray listed
12-mer
Pineal tetrapeptide · telomere research
Nasal spray listed